Outcome of gastric cancer in the elderly: a population-based evaluation of the Munich Cancer Registry

Background Gastric cancer accounts for 5 % of cancer deaths. Proportions of older stomach cancer patients are increasing. Despite the still poor prognosis, standardised treatment has achieved improvements; nonetheless it is questionable whether all age groups have benefitted. Age and outcome need to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2016-07, Vol.19 (3), p.713-722
Hauptverfasser:	Schlesinger-Raab, Anne, Mihaljevic, André L., Egert, Silvia, Emeny, Rebecca, Jauch, Karl-Walter, Kleeff, Jörg, Novotny, Alexander, Nüssler, Natascha C., Rottmann, Miriam, Schepp, Wolfgang, Schmitt, Wolfgang, Schubert-Fritschle, Gabriele, Weber, Bernhard, Schuhmacher, Christoph, Engel, Jutta
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Surgery Adenocarcinoma - epidemiology Adenocarcinoma - mortality Adenocarcinoma - pathology Adenocarcinoma - therapy Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Research Carcinoma, Signet Ring Cell - epidemiology Carcinoma, Signet Ring Cell - mortality Carcinoma, Signet Ring Cell - pathology Carcinoma, Signet Ring Cell - therapy Combined Modality Therapy Female Follow-Up Studies Gastrectomy Gastric cancer Gastroenterology Germany - epidemiology Humans Male Medicine Medicine & Public Health Middle Aged Neoplasm Grading Neoplasm Staging Oncology Original Article Prognosis Registries Stomach Neoplasms - epidemiology Stomach Neoplasms - mortality Stomach Neoplasms - pathology Stomach Neoplasms - therapy Surgical Oncology Survival Rate Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background Gastric cancer accounts for 5 % of cancer deaths. Proportions of older stomach cancer patients are increasing. Despite the still poor prognosis, standardised treatment has achieved improvements; nonetheless it is questionable whether all age groups have benefitted. Age and outcome need to be examined in a population-based setting. Methods Analyses included Munich Cancer Registry (MCR) data from 8601 invasive gastric cancer patients, diagnosed between 1998 and 2012. Tumour and therapy characteristics and outcome were analysed by two age groups (
ISSN:	1436-3291 1436-3305
DOI:	10.1007/s10120-015-0527-7